Yolanda S. Kap - Concepedia

Author

Yolanda S. Kap

Biomedical Primate Research Centre ORCID

Also Known As

Y S Kap, Yolanda Kap, Yolanda S Kap, Yolanda S. Kap, Yolanda S. Kap

Publications

1.2K

Citations

H-Index

Concepts

All Affiliations

Biomedical Primate Research Centre University Medical Center Groningen Erasmus MC Erasmus University Rotterdam Medical University of Vienna

About

Yolanda S. Kap is an author at Biomedical Primate Research Centre specializing in medicine, immunology, and autoimmunity.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	12	12	536
2	Allergy	5	5	183
3	Cell Biology	4	4	135
4	Health Sciences	2	2	199
5	Diabetes	1	1	184

Yolanda S. Kap

Publications

950

Citations

H-Index

Page 1

	Year	Citations
Tracing from Fat Tissue, Liver, and Pancreas: A Neuroanatomical Framework for the Role of the Brain in Type 2 Diabetes Felix Kreier, Yolanda S. Kap, Thomas C. Mettenleiter, Endocrinology Sc Adipose TissueHomeostatic MechanismInsulin SignalingObesityMetabolic Syndrome	2005	184
Enhanced axonal response of mitochondria to demyelination offers neuroprotection: implications for multiple sclerosis Simon Licht‐Mayer, G. Campbell, Marco A. Cañizares, Acta Neuropathologica	2020	89
Induction of Progressive Demyelinating Autoimmune Encephalomyelitis in Common Marmoset Monkeys Using MOG<sub>34-56</sub>Peptide in Incomplete Freund Adjuvant S. Anwar Jagessar, Yolanda S. Kap, Nicole Heijmans, Journal of Neuropathology & Experimental Neurology Marmoset MonkeysImmunologyInnate ImmunityImmune SystemInflammation	2010	76
Fast Progression of Recombinant Human Myelin/Oligodendrocyte Glycoprotein (MOG)-Induced Experimental Autoimmune Encephalomyelitis in Marmosets Is Associated with the Activation of MOG34–56-Specific Cytotoxic T Cells Yolanda S. Kap, Paul A. Smith, S. Anwar Jagessar, The Journal of Immunology	2008	64
Induction of Experimental Autoimmune Encephalomyelitis With Recombinant Human Myelin Oligodendrocyte Glycoprotein in Incomplete Freund’s Adjuvant in Three Non-human Primate Species Krista G. Haanstra, S. Anwar Jagessar, Anne-Laure Bauchet, Journal of Neuroimmune Pharmacology	2013	54
Late B Cell Depletion with a Human Anti-Human CD20 IgG1κ Monoclonal Antibody Halts the Development of Experimental Autoimmune Encephalomyelitis in Marmosets Yolanda S. Kap, Nikki van Driel, Erwin L. A. Blezer, The Journal of Immunology	2010	53
The human CMV-UL86 peptide 981–1003 shares a crossreactive T-cell epitope with the encephalitogenic MOG peptide 34–56, but lacks the capacity to induce EAE in rhesus monkeys Herbert Brok, Leonie A. Boven, Marjan van Meurs, Journal of Neuroimmunology Autoimmune DiseaseRhesus MonkeysCrossreactive T-cell EpitopeImmunologyImmune Regulation	2006	52
The Primate EAE Model Points at EBV-Infected B Cells as a Preferential Therapy Target in Multiple Sclerosis Bert A. ‘t Hart, S. Anwar Jagessar, Krista G. Haanstra, Frontiers in Immunology	2013	51
Oxidative Injury and Iron Redistribution Are Pathological Hallmarks of Marmoset Experimental Autoimmune Encephalomyelitis Jordon Dunham, Jan Bauer, G. Campbell, Journal of Neuropathology & Experimental Neurology Iron MetabolismImmunologyCell DeathPathologyRedox Biology	2017	37
Targeted Diet Modification Reduces Multiple Sclerosis–like Disease in Adult Marmoset Monkeys from an Outbred Colony Yolanda S. Kap, Carien Bus‐Spoor, Nikki van Driel, The Journal of Immunology	2018	35

Page 1